Frontlight ResearchEarly access
Trial site
Zhengzhou Second Hospital
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Diabetic eye disease2 trials
- Glioblastoma2 trials
- Brain metastases1 trial
- Macular degeneration1 trial
- Meningioma1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Peking University Third Hospital2 trials
- Beletalent (Zhuhai) Pharmaceutical Co., Ltd1 trial
- BioDlink Biopharm Co., Ltd.1 trial
- EnnovaBio1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Glioblastoma2 recruiting
- Brain metastases1 recruiting
- Diabetic eye disease1 recruiting
- Meningioma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026